Clearmind Medicine Inc.(CMND US)
$5.97-0.152.52%
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions CAD (ex. Per Share) | FY201710/31/2017 | FY201810/31/2018 | FY201910/31/2019 | FY202010/31/2020 | FY202110/31/2021 | FY202210/31/2022 | FY202310/31/2023 | FY202410/31/2024 | FY202510/31/2025 | Last 12M04/30/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | 7.6 | 12.9 | 5.5 | 16.0 | ||||||||
| Short Term Investments | 0.1 | 0.6 | 2.3 | 3.1 | ||||||||
| Cash and Short Term Investments | 7.8 | 13.4 | 7.9 | 19.1 | ||||||||
| Net Receivables | 0.3 | 0.4 | 0.5 | 0.8 | ||||||||
| Inventory | - | - | - | - | ||||||||
| Other Current Assets | - | - | - | - | ||||||||
| Total Current Assets | 8.1 | 13.9 | 8.4 | 20.1 | ||||||||
| Property, Plant & Equipment | 0.0 | 0.1 | 0.0 | 0.1 | ||||||||
| Long Term Investments | - | - | - | 0.0 | ||||||||
| Other Non-Current Assets | -0.0 | 0.0 | 0.0 | - | ||||||||
| Total Non-Current Assets | 0.2 | 0.3 | 0.2 | 0.3 | ||||||||
| Total Assets | 8.4 | 14.2 | 8.6 | 20.4 | ||||||||
| Account Payables | 0.9 | 1.0 | 1.0 | - | ||||||||
| Short Term Debt | - | - | 2.5 | 0.1 | ||||||||
| Deferred Revenue | - | - | - | - | ||||||||
| Other Current Liabilities | 6.1 | 6.9 | 3.3 | 4.1 | ||||||||
| Total Current Liabilities | 7.0 | 8.1 | 6.9 | 4.2 | ||||||||
| Long Term Debt | - | - | - | - | ||||||||
| Other Non-Current Liabilities | - | - | - | - | ||||||||
| Total Non-Current Liabilities | - | 0.0 | - | 0.1 | ||||||||
| Total Liabilities | 7.0 | 8.1 | 6.9 | 4.3 | ||||||||
| Common Stock | 24.1 | 47.3 | 37.1 | 60.0 | ||||||||
| Retained Earnings | -26.4 | -47.0 | -39.2 | -47.5 | ||||||||
| Total Stockholders Equity | 1.4 | 6.1 | 1.7 | 16.2 | ||||||||
| Total Liabilities and Equity | 8.4 | 14.2 | 8.6 | 20.4 | ||||||||